J. U. Lovegrove

559 total citations
16 papers, 430 citations indexed

About

J. U. Lovegrove is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, J. U. Lovegrove has authored 16 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in J. U. Lovegrove's work include Protease and Inhibitor Mechanisms (5 papers), Genomic variations and chromosomal abnormalities (2 papers) and Healthcare Policy and Management (2 papers). J. U. Lovegrove is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Genomic variations and chromosomal abnormalities (2 papers) and Healthcare Policy and Management (2 papers). J. U. Lovegrove collaborates with scholars based in United Kingdom, Netherlands and India. J. U. Lovegrove's co-authors include David Whitehouse, D. A. HOPKINSON, S Gallivan, G. Gaskin, Charles D. Pusey, Megan Griffith, D. B. Whitehouse, K. Watterson, J. Stark and Oswaldo Valencia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and FEBS Letters.

In The Last Decade

J. U. Lovegrove

16 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. U. Lovegrove United Kingdom	10	138	108	75	72	52	16	430
Anand Pathak United States	11	153 1.1×	40 0.4×	53 0.7×	47 0.7×	41 0.8×	25	395
Hyung Bae Moon South Korea	10	144 1.0×	40 0.4×	93 1.2×	187 2.6×	78 1.5×	17	516
Yoshihiro Noji Japan	10	68 0.5×	47 0.4×	147 2.0×	39 0.5×	131 2.5×	20	389
Jessica A. Yu United States	15	148 1.1×	144 1.3×	92 1.2×	140 1.9×	175 3.4×	21	592
Annabelle Heier Switzerland	9	278 2.0×	60 0.6×	39 0.5×	50 0.7×	41 0.8×	16	548
Tetsuo Imazu Japan	7	275 2.0×	70 0.6×	57 0.8×	94 1.3×	30 0.6×	28	419
Farooq Siddiqui United States	10	133 1.0×	40 0.4×	55 0.7×	24 0.3×	30 0.6×	19	453
Juan Zhao China	12	227 1.6×	40 0.4×	121 1.6×	75 1.0×	36 0.7×	34	477
Yvonne Teng Singapore	8	182 1.3×	77 0.7×	78 1.0×	34 0.5×	33 0.6×	11	486
J.P. Obrecht Switzerland	12	75 0.5×	81 0.8×	152 2.0×	43 0.6×	66 1.3×	32	460

Countries citing papers authored by J. U. Lovegrove

Since Specialization

Citations

This map shows the geographic impact of J. U. Lovegrove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. U. Lovegrove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. U. Lovegrove more than expected).

Fields of papers citing papers by J. U. Lovegrove

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. U. Lovegrove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. U. Lovegrove. The network helps show where J. U. Lovegrove may publish in the future.

Co-authorship network of co-authors of J. U. Lovegrove

This figure shows the co-authorship network connecting the top 25 collaborators of J. U. Lovegrove. A scholar is included among the top collaborators of J. U. Lovegrove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. U. Lovegrove. J. U. Lovegrove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Nagl, Sylvia, et al.. (2004). Novel sites in the p65 subunit of NF‐κB interact with TFIIB to facilitate NF‐κB induced transcription. FEBS Letters. 561(1-3). 217–222. 9 indexed citations

Stark, J., et al.. (2000). Mortality rates after surgery for congenital heart defects in children and surgeons' performance. The Lancet. 355(9208). 1004–1007. 100 indexed citations

Lovegrove, J. U., Chris Sherlaw‐Johnson, Oswaldo Valencia, Tom Treasure, & S Gallivan. (1999). Monitoring the performance of cardiac surgeons. Journal of the Operational Research Society. 50(7). 684–689. 41 indexed citations

Yip, Shea Ping, J. U. Lovegrove, Nadia A. Rana, D. A. HOPKINSON, & David Whitehouse. (1999). Mapping Recombination Hotspots in Human Phosphoglucomutase (PGM1). Human Molecular Genetics. 8(9). 1699–1706. 25 indexed citations

Whitehouse, David, Janine Tomkins, J. U. Lovegrove, D. A. HOPKINSON, & W. Owen McMillan. (1998). A phylogenetic approach to the identification of phosphoglucomutase genes. Molecular Biology and Evolution. 15(4). 456–462. 39 indexed citations

Lovegrove, J. U., S. JEREMIAH, Godfrey T. Gillett, et al.. (1997). A new alpha 1‐antitrypsin mutation, Thr–Met 85, (PI Z_bristol) associated with novel electrophoretic properties. Annals of Human Genetics. 61(5). 385–391. 13 indexed citations

Tomkins, Janine, M. Fox, J. U. Lovegrove, et al.. (1997). Molecular and cytological investigations of phosphoglucomutase (PGM1) in the K562 cell line. Annals of Human Genetics. 61(2). 99–108. 3 indexed citations

Lovegrove, J. U., et al.. (1997). A new alpha 1-antitrypsin mutation, Thr–Met 85, (PI Zbristol) associated with novel electrophoretic properties. Annals of Human Genetics. 61(5). 385–391. 4 indexed citations

Griffith, Megan, J. U. Lovegrove, G. Gaskin, D. B. Whitehouse, & Charles D. Pusey. (1996). C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrology Dialysis Transplantation. 11(3). 438–443. 61 indexed citations

10.

Griffith, Megan, et al.. (1996). C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrology Dialysis Transplantation. 11(3). 438–443. 46 indexed citations

11.

Whitehouse, D. B., J. U. Lovegrove, Giorgina Mieli‐Vergani, A P Mowat, & D. A. HOPKINSON. (1994). ‘SZ like’α1‐antitrypsin phenotypes in PI ZZ children with liver disease. Annals of Human Genetics. 58(1). 11–17. 7 indexed citations

12.

Putt, W., Martine Hollyoake, J. U. Lovegrove, et al.. (1993). The classical human phosphoglucomutase (PGM1) isozyme polymorphism is generated by intragenic recombination.. Proceedings of the National Academy of Sciences. 90(22). 10730–10733. 14 indexed citations

13.

Abbott, Catherine M., J. U. Lovegrove, D. B. Whitehouse, D. A. HOPKINSON, & Sue Povey. (1992). Prenatal diagnosis of alpha‐1‐antitrypsin deficiency by PCR of linked polymorphisms: A study of 17 cases. Prenatal Diagnosis. 12(4). 235–240. 5 indexed citations

14.

Whitehouse, David, W. Putt, J. U. Lovegrove, et al.. (1992). Phosphoglucomutase 1: complete human and rabbit mRNA sequences and direct mapping of this highly polymorphic marker on human chromosome 1.. Proceedings of the National Academy of Sciences. 89(1). 411–415. 47 indexed citations

15.

Whitehouse, David, J. U. Lovegrove, & D. A. HOPKINSON. (1989). Variation in alpha-1-antitrypsin phenotypes associated with penicillamine therapy. Clinica Chimica Acta. 179(1). 109–115. 15 indexed citations

16.

Whitehouse, David, Catherine M. Abbott, J. U. Lovegrove, et al.. (1989). Genetic studies on a new deficiency gene (PI*Ztun) at the PI locus.. Journal of Medical Genetics. 26(12). 744–749. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact